Paper87477
Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.
Parham P and 2 others. J Immunol, 1979. Cited by 710 papers, by iCite.
Cite this record
ConductScience Library. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. Papers, record 87477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/87477
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| HLA Antigens | Major topic |
| Animals | |
| Binding Sites, Antibody | |
| Chemical Phenomena | |
| Chemistry | |
| Chromosome Mapping | |
| Clone Cells | |
| Epitopes | |
| Genetic Code | |
| Humans | |
| Mice | |
| Papain | |
| beta 2-Microglobulin |
Source PubMed
Cited by235
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 710 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42929886 | Cytokine-Mediated Plasticity in the Molecular Requirements for Peptide-Loading Complex Formation and Antigen Presentation. | Cells | 2026 | https://conductscience.org/library/papers/42929886 | PubMed |
| 41734996 | Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41734996 | PubMed |
| 40872797 | SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II Expression. | Viruses | 2025 | https://conductscience.org/library/papers/40872797 | PubMed |
| 40749828 | Molecular characterization of the archaic HLA-B∗73:01 allele reveals presentation of a unique peptidome and skewed engagement by KIR2DL2. | J Biol Chem | 2025 | https://conductscience.org/library/papers/40749828 | PubMed |
| 39476840 | An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania. | Cell | 2024 | https://conductscience.org/library/papers/39476840 | PubMed |
| 39057057 | Conformational Alterations of the Cell Surface of Monomeric and Dimeric β2m-Free HLA-I (Proto-HLA) May Enable Novel Immune Functions in Health and Disease. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39057057 | PubMed |
| 38939414 | Characterising the HLA-I immunopeptidome of plasma-derived extracellular vesicles in patients with melanoma. | J Extracell Biol | 2024 | https://conductscience.org/library/papers/38939414 | PubMed |
| 38900146 | Multimodal HLA-I genotype regulation by human cytomegalovirus US10 and resulting surface patterning. | Elife | 2024 | https://conductscience.org/library/papers/38900146 | PubMed |
| 38733995 | Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules. | Structure | 2024 | https://conductscience.org/library/papers/38733995 | PubMed |
| 38596688 | Differences in F pocket impact on HLA I genetic associations with autoimmune diabetes. | Front Immunol | 2024 | https://conductscience.org/library/papers/38596688 | PubMed |
| 38542184 | Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38542184 | PubMed |
| 37773139 | Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer's disease. | Cell Biosci | 2023 | https://conductscience.org/library/papers/37773139 | PubMed |
| 37737643 | Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing. | J Immunol | 2023 | https://conductscience.org/library/papers/37737643 | PubMed |
| 37674626 | Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma. | Mol Ther Oncolytics | 2023 | https://conductscience.org/library/papers/37674626 | PubMed |
| 37207206 | Effects of HLA single chain trimer design on peptide presentation and stability. | Front Immunol | 2023 | https://conductscience.org/library/papers/37207206 | PubMed |
| 36165200 | Cross-Talk between HLA Class I and TLR4 Mediates P-Selectin Surface Expression and Monocyte Capture to Human Endothelial Cells. | J Immunol | 2022 | https://conductscience.org/library/papers/36165200 | PubMed |
| 36134954 | Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis. | Antibodies (Basel) | 2022 | https://conductscience.org/library/papers/36134954 | PubMed |
| 36010968 | Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36010968 | PubMed |
| 35318648 | Tumour-associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles. | Immunology | 2022 | https://conductscience.org/library/papers/35318648 | PubMed |
| 35303241 | Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor. | Immunol Res | 2022 | https://conductscience.org/library/papers/35303241 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| HLA-B | 3106 | PubTator's text mining | https://conductscience.org/library/genes/3106 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/87477
GET https://conductscience.org/api/papers/v1/87477/cited_by?page=2